Portfolio (Quarterly)
Guide ↗
BRAIDWELL LP
· CIK 0001920938| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CAI | CARIS LIFE SCIENCES INC | Healthcare | 7,816,142.0 | $210.9M | 6.74% | +500K | +6.8% | $26.98 | -46.1% |
| 2 | GKOS | GLAUKOS CORP | Healthcare | 921,979.0 | $104.1M | 3.33% | +142K | +18.2% | $112.91 | +25.9% |
| 3 | HNGE | HINGE HEALTH INC | Healthcare | 1,304,623.0 | $60.6M | 1.94% | +394K | +43.3% | $46.45 | +16.0% |
| 4 | NEO | NEOGENOMICS INC | Healthcare | 4,632,801.0 | $54.5M | 1.74% | +2.9M | +161.6% | $11.76 | -28.9% |
| 5 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 1,273,935.0 | $52.5M | 1.68% | +439K | +52.6% | $41.21 | +107.1% |
| 6 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 1,858,109.0 | $50.5M | 1.61% | +1.3M | +214.0% | $27.16 | +15.4% |
| 7 | CVS | CVS HEALTH CORP | Healthcare | 564,200.0 | $44.8M | 1.43% | +126K | +28.6% | $79.36 | +22.4% |
| 8 | VERA | VERA THERAPEUTICS INC | Healthcare | 784,742.0 | $39.7M | 1.27% | +312K | +66.0% | $50.64 | -21.9% |
| 9 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 601,520.0 | $35.7M | 1.14% | +74K | +13.9% | $59.43 | -12.8% |
| 10 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 454,259.0 | $35.3M | 1.13% | +178K | +64.2% | $77.81 | +8.6% |
| 11 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 3,061,222.0 | $34.6M | 1.11% | +2.8M | +1294.7% | $11.31 | -37.1% |
| 12 | — | ENGENE HOLDINGS INC | — | 3,131,319.0 | $28.3M | 0.90% | +865K | +38.2% | $9.03 | — |
| 13 | — | BRIGHT MINDS BIOSCIENCES INC | — | 324,358.0 | $25.3M | 0.81% | +21K | +6.8% | $78.04 | — |
| 14 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 927,524.0 | $19.3M | 0.62% | +191K | +25.9% | $20.86 | +42.9% |
| 15 | — | ZURA BIO LTD | — | 3,180,389.0 | $16.7M | 0.53% | +708K | +28.6% | $5.24 | — |
| 16 | — | SURROZEN INC | — | 470,000.0 | $10.6M | 0.34% | +330K | +235.7% | $22.60 | — |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%